` 1515 (China Resources Medical Holdings Company Ltd) vs Hang Seng (Hong Kong) Comparison - Alpha Spread

1515
vs
H
Hang Seng (Hong Kong)

Over the past 12 months, China Resources Medical Holdings Company Ltd has underperformed Hang Seng (Hong Kong), delivering a return of -16% compared to the Hang Seng (Hong Kong)'s +29% growth.

Stocks Performance
1515 vs Hang Seng (Hong Kong)

Loading
1515
Hang Seng (Hong Kong)
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
1515 vs Hang Seng (Hong Kong)

Loading
1515
Hang Seng (Hong Kong)
Difference
www.alphaspread.com

Performance By Year
1515 vs Hang Seng (Hong Kong)

Loading
1515
Hang Seng (Hong Kong)
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
China Resources Medical Holdings Company Ltd vs Peers

Hang Seng (Hong Kong)
1515
HCA
4013
IHH
RDOR3
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

China Resources Medical Holdings Company Ltd
Glance View

Market Cap
4.2B HKD
Industry
Health Care

China Resources Medical Holdings Co., Ltd. operates as an investment holding company. The company is headquartered in Beijing, Beijing. The company went IPO on 2013-11-29. Along with subsidiaries, the Company operates its business through four segments. The GPO Business segment is involved in the sales of pharmaceuticals, medical devices and medical consumables to Jian Gong Hospital, the Internet of things (IOT) Hospitals and external customers. The General Healthcare Services segment provides hospital services provided through Jian Gong Hospital and 999 Medical Clinic (Shenzhen) Co., Ltd. The Hospital Management and Consulting Services segment provides comprehensive management and consulting services to IOT Hospitals and sponsored hospitals and receives an annual fee. The Other Hospital-Derived Services segment provides medical consultation service to third parties.

Intrinsic Value
6.62 HKD
Undervaluation 51%
Intrinsic Value
Price
Back to Top